Vertex Pharmaceuticals (VRTX) Common Equity (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Common Equity of $20.25 billion for Q2 2026, up 17.9% from $17.18 billion a year earlier and up 4.6% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Vertex Pharmaceuticals' Common Equity came in at $18.67 billion, up 13.7% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of 16.5% (FY2020 to FY2025).
- In prior years, Vertex Pharmaceuticals' Common Equity was $16.41 billion in FY2024 (-6.7%), $17.58 billion in FY2023 (+26.4%), $13.91 billion in FY2022 (+37.7%) and $10.1 billion in FY2021 (+16.3%).
- The Q2 2026 figure stands as the highest quarterly Common Equity in data going back to Q4 2009.
- On a year-over-year basis, Common Equity has increased in each of the last five quarters, with growth averaging 6.6% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2022, with growth of 37.7%; the weakest was Q1 2025, with a decline of 11.1%.
- According to Business Quant data, Common Equity for the three prior quarters was $19.36 billion (Q1 2026), $18.67 billion (Q4 2025) and $17.32 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 20.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.25 Bn |
| Mar 31, 2026 | 19.36 Bn |
| Dec 31, 2025 | 18.67 Bn |
| Sep 30, 2025 | 17.32 Bn |
| Jun 30, 2025 | 17.18 Bn |
| Mar 31, 2025 | 16.50 Bn |
| Dec 31, 2024 | 16.41 Bn |
| Sep 30, 2024 | 15.63 Bn |
| Jun 30, 2024 | 14.77 Bn |
| Mar 31, 2024 | 18.55 Bn |
| Dec 31, 2023 | 17.58 Bn |
| Sep 30, 2023 | 16.51 Bn |
| Jun 30, 2023 | 15.47 Bn |
| Mar 31, 2023 | 14.43 Bn |
| Dec 31, 2022 | 13.91 Bn |
| Sep 30, 2022 | 13.03 Bn |
| Jun 30, 2022 | 11.93 Bn |
| Mar 31, 2022 | 10.91 Bn |
| Dec 31, 2021 | 10.10 Bn |
| Sep 30, 2021 | 9.53 Bn |
API Access
Vertex Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();